| Raakhee Vijayaraghavan | Inc., The University of Texas MD Anderson Cancer Center |
| Toshinori Hinoue | Van Andel Research Institute, The University of Texas MD Anderson Cancer Center |
| Hui Shen | Van Andel Research Institute, The University of Texas MD Anderson Cancer Center |
| Hui Shen | Van Andel Research Institute, The University of Texas MD Anderson Cancer Center |
| Neeraj Salathia | Inc., The University of Texas MD Anderson Cancer Center |
| Marina Bibikova | Inc., The University of Texas MD Anderson Cancer Center |
| Marina Bibikova | Inc., The University of Texas MD Anderson Cancer Center |
| Richard Shen | Inc., The University of Texas MD Anderson Cancer Center |
| Charles Lu | The University of Texas MD Anderson Cancer Center |
| Scott Kopetz | The University of Texas MD Anderson Cancer Center |
| Funda Meric-Bernstam | Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center |
| Peter W Laird | Van Andel Research Institute, The University of Texas MD Anderson Cancer Center |
| Peter W Laird | Van Andel Research Institute, The University of Texas MD Anderson Cancer Center |
| Jian-Bing Fan | Inc., The University of Texas MD Anderson Cancer Center |
| Jian-Bing Fan | Inc., The University of Texas MD Anderson Cancer Center |